• Americans Place High Value on Eyesight, Yet Many Still Lack Vision Coverage (PR Newswire)
   
• Miss Universe 2008 Dayana Mendoza Joins the Fight Against AIDS by Getting Tested for HIV (PR Newswire)
   
• New Findings Spark 'What You Do Matters' Call to Action to Educate Women on Reducing Cancer Risks (PR Newswire)
   
• First European Survey to Study the Fit and Feel of Condoms (PR Newswire)
   
• TransUnion Healthcare Survey Finds That Nearly Half of Respondents Experienced Up to 10 Percent Increases in the Uninsured and Underinsured Populations (PR Newswire)
   
• Lawsuit Against Social Security Administration and HHS Filed Today (PR Newswire)
   
• A new study supports the prognostic value of the PCA3 prostate cancer marker (PR Newswire)
   
• Paper in Cell Cycle Reports Alfacell's ONCONASE(R) Targets siRNA (PR Newswire)
   
• FDA Approves New Injection Site for RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment (PR Newswire)
   
• UPDATE: Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH) (PR Newswire)
   
• Cardiome Provides Regulatory Update (PR Newswire)
   
• Millennium Ranks in the Top 10 Best Biopharma Employers in the World by Science Magazine (PR Newswire)
   
• EMD Serono Named as a Top Employer by Science Magazine (PR Newswire)
   
• Boston Scientific Comments on Involuntary Selling of Its Stock by Co-Founders (PR Newswire)
   
• Nasdaq Grants VirtualScopics' Request for Continued Listing (PR Newswire)
   
• CEL-SCI Takes Delivery of New Manufacturing Facility (PR Newswire)
   
• Abbott Opens New Research Facility and Pilot Plant in Ludwigshafen (PR Newswire)
   
• AstraZeneca's Purplepill.com Tops the List of Most Visited Pharmaceutical Brand Web Sites in Q2 2008 (PR Newswire)
   
• Zargis Receives Additional Contracts from U.S. Army (PR Newswire)
   
• Sagent Pharmaceuticals, Inc. and Itochu Chemical Frontier Corporation Announce Development and Manufacturing Collaboration (PR Newswire)
   
• Mirixa Corporation and the APhA Foundation Form Partnership (PR Newswire)
   
• China West II Files $6 Million Arbitration Against Genesis (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

• Economic Crisis Making You Anxious or Depressed? (PR Newswire)
   
• Physician Reminder: Importation is Illegal (PR Newswire)
   
• Illegal Botox Scammers a Public Threat (PR Newswire)
   
• Michigan Democratic Party: Rep. Jones, Local Health Care Workers to Sound the Alarm on McCain's Radical Health Care Plan (PR Newswire)
   
• Independent Pharmacies Rank Highest Nationally in Overall Customer Satisfaction (PR Newswire)
   
• United Spinal Association Publishes Fire Safety for Wheelchair Users Booklet (PR Newswire)
   
• WomenHeart Offers Free Guide to Help Women Reduce Their Risk of Heart Disease (PR Newswire)
   
• Plastic Surgeons Face War Injuries From Iraq to Inner-City Violence (PR Newswire)
   
• New Evidence Highlights Dangers of Mercury Toxicity in Fish (PR Newswire)
   
• Protein Shown to Play a Key Role in Normal Development of Nervous System (PR Newswire)
   
• Fat Injections Can Improve Breast Reconstruction - Jury's out on Augmentation (PR Newswire)
   
• Wild Blueberries Take Top Spot in New Antioxidant Research Study (PR Newswire)
   
• In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices (PR Newswire)
   
• World Renowned Champalimaud Foundation Extends its Mission with Groundbreaking for Cutting-Edge Research Center (PR Newswire)
   
• Touchstone Health Partners with the American Heart Association and American Stroke Association to Fight Cardiovascular Disease Among Seniors (PR Newswire)
   
• Millstone Medical Outsourcing Acquires New Facility to Accommodate Growing Business, Provide Additional Clean Room Capacity (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

 

• FDA Hearing on Kids' Cold Medicines Spells Greater Confusion for Parents (PR Newswire)
   
• Statement from CHPA on the Voluntary Label Updates to Oral OTC Children's Cough and Cold Medicines (PR Newswire)
   
• New Survey Uncovers Critical Need for Education on Key Issues in Parkinson's Disease Management (PR Newswire)
   
• Lawmakers Consider Legislation to Reduce Obesity in the Workplace (PR Newswire)
   
• Veterinarians Say Good Hygiene, Common Sense Key to Healthy Pets and Families (PR Newswire)
   
• Pregnant Women Missing Important Protection During Flu Season (PR Newswire)
   
• The Unraveling Economy Puts Seattle Residents Under Pressure (PR Newswire)
   
• APA Poll Finds Economic Stress Taking Toll on Women, Hispanics (PR Newswire)
   
• Eli Lilly and Company Resolves Investigation Involving Numerous States (PR Newswire)
   
• NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium (PR Newswire)
   
• Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine (PR Newswire)
   
• Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (PR Newswire)
   
• Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients (PR Newswire)
   
• BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine (PR Newswire)
   
• Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds (PR Newswire)
   
• Reliant Technologies Announces FDA 510(K) Clearance of New Handpieces for Skin Resurfacing and Surgical Applications (PR Newswire)
   
• The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline (PR Newswire)
   
• China Medical Technologies Acquires HPV-DNA Biosensor Chip and SPR-based Analysis System (PR Newswire)
   
• Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program (PR Newswire)
   
• Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection (PR Newswire)
   
• CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect (PR Newswire)
   
• Shengtai Pharmaceutical Receives GMP Certificate for Its New Glucose Manufacturing Facility (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

 

• Registered Nurses at UW Medical Center Reach Tentative Agreement With Hospital That Maintains Patient Safety (PR Newswire)
   
• Academic Medicine Means Business for Ohio: $37.2 Billion Economic Impact for the State (PR Newswire)
   
• Modern Physician Names California Doctor as Physician Entrepreneur of the Year (PR Newswire)
   
• Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use (PR Newswire)
   
• Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years (PR Newswire)
   
• Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial (PR Newswire)
   
• Shire Announces Results from a Multidisciplinary Analysis of the Drug Release Profiles of LIALDA(R) (mesalamine) and Asacol(R) (mesalamine) for the Treatment of Ulcerative Colitis (UC) at the American College of Gastroenterology (ACG) Meeting (PR Newswire)
   
• New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study (PR Newswire)
   
• New Data Show alli(R) (Orlistat 60 mg) Diet Plan May Have a Positive Effect on Family Members (PR Newswire)
   
• CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients (PR Newswire)
   
• International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer (PR Newswire)
   
• BioMS Medical's relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board (PR Newswire)
   
• MedX(R) Receives FDA Clearance for Oralase(TM), an Advanced Laser Treatment for Pain (PR Newswire)
   
• Complete Genomics Launches, Becomes World's First Large-Scale Human Genome Sequencing Company (PR Newswire)
   
• Lilly to Acquire ImClone Systems in $6.5 Billion Transaction (PR Newswire)
   
• NUCRYST Receives Nasdaq Deficiency Notice (PR Newswire)
   
• deCODE Receives Nasdaq Deficiency Notice Relating to Market Value (PR Newswire)
   
• Galenea and Otsuka Pharmaceutical Extend & Expand Schizophrenia Research Collaboration (PR Newswire)
   
• Perrigo Acquires Mexican Manufacturer Laboratorios Diba, S.A. (PR Newswire)
   
• Oncalis AG Licenses PI3K Inhibitors From ChemDiv Inc. (PR Newswire)
   
• Grifols Breaks Ground on New IVIG Facility (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs

• Vice Presidential Candidates Missed Opportunity for Critical Dialogue on Affordability of Health Care (PR Newswire)
   
• Susan G. Komen for the Cure(R), Speaker Dennis O'Brien, Obama and McCain Health Care Advisors, Breast Cancer Survivors and Advocates Call for Needed Health Care Reforms (PR Newswire)
   
• AHIP Commends Congress for Passage of Bipartisan Mental Health Parity Legislation (PR Newswire)
   
• APHA Applauds Congress for Passing Long-Overdue Mental Health Legislation (PR Newswire)
   
• Michigan Dental Association Stops Illegal Practice of Dentistry, Safeguards Public (PR Newswire)
   
• Response to NY Post Article Concerning Victor Cosmeceuticals (PR Newswire)
   
• GPhA Praises California Governor Schwarzenegger for Signing Workable E-Pedigree System (PR Newswire)
   
• Can Your Employees Survive the Financial Crunch of an Illness? (PR Newswire)
   
• BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board (PR Newswire)
   
• deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders (PR Newswire)
   
• NIH's National Children's Study Enters Next Phase (PR Newswire)
   
• AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) (PR Newswire)
   
• BrainLAB to Receive $4.38 Million Lawsuit Costs From Medtronic (PR Newswire)
   
• Cardinal Health Inc., Agrees to Pay $34 Million to Settle Claims That it Failed to Report Suspicious Sales of Widely-Abused Controlled Substances (PR Newswire)
   
• Cardinal Health Resolves Controlled Substance License Suspensions (PR Newswire)
   
• Simbionix Launches Innovative Patient-Specific Simulation (PR Newswire)
   
• Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics (PR Newswire)
   
• Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement (PR Newswire)
   
• Filtrona Acquires Lendell Manufacturing (PR Newswire)
   
• Weis Markets Completes Rollout of New 90-Day $9.99 Prescription Plan for 350+ Generic Prescriptions (PR Newswire)
   
• Ground is Broken for New Hospital in New Jersey: University Medical Center of Princeton at Plainsboro (PR Newswire)
   
• Children's Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey (PR Newswire)
   

Back to Top Navigational Aid

Links:  Pharm/Biotech Resources,  Pharm/Biotech Jobs